Search research articles
Contact Us
Filters
Showing results (41-50 of 78) with videos related to
Page
of 8
Sort By:
Journal of Neurochemistry
|
May 1, 1989
Immunochemical properties of ubiquitin conjugates in the paired helical filaments of Alzheimer disease
G Perry, P Mulvihill, V A Fried, et al.
American Journal of Hypertension
|
November 1, 1993
Pharmacokinetics of fluvastatin and specific drug interactions
H T Smith, L A Jokubaitis, A J Troendle, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 28, 2009
An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK
C Pratoomsoot, H T Smith, A Kalsekar, et al.
Medicine and Science in Sports and Exercise
|
August 14, 2014
The effects of inspiratory muscle training in older adults
Dean E Mills, Michael A Johnson, Yvonne A Barnett, et al.
Brain Research
|
January 18, 1991
Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease
C Bancher, I Grundke-Iqbal, K Iqbal, et al.
Transplantation Proceedings
|
September 2, 1998
Relative bioavailability of Neoral versus Sandimmune in the presence of a P450IIIA and P-glycoprotein inhibitor
M G Choc, E A Mueller, W T Robinson, et al.
Science (New York, N.Y.)
|
February 21, 1986
Expression cloning of a lymphocyte homing receptor cDNA: ubiquitin is the reactive species
T St John, W M Gallatin, M Siegelman, et al.
Pharmaceutical Research
|
October 1, 1987
Multiple-dose pharmacokinetics of clozapine in patients
M G Choc, R G Lehr, F Hsuan, et al.
The Journal of Endocrinology
|
January 21, 2006
Somatostatin receptor subtype expression in the human heart: differential expression by myocytes and fibroblasts
William H T Smith, R Unnikrishnan Nair, Dawn Adamson, et al.
Journal of Clinical Pharmacology
|
February 1, 1997
Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonist
R M Lush, B Meadows, A T Fojo, et al.
Page
of 8
Search research articles
Search
Showing results (41-50 of 78) with videos related to
Sort By:
Page
of 8
Journal of Neurochemistry
|
May 1, 1989
Immunochemical properties of ubiquitin conjugates in the paired helical filaments of Alzheimer disease
G Perry, P Mulvihill, V A Fried, et al.
American Journal of Hypertension
|
November 1, 1993
Pharmacokinetics of fluvastatin and specific drug interactions
H T Smith, L A Jokubaitis, A J Troendle, et al.
Diabetic Medicine : a Journal of the British Diabetic Association
|
August 28, 2009
An estimation of the long-term clinical and economic benefits of insulin lispro in Type 1 diabetes in the UK
C Pratoomsoot, H T Smith, A Kalsekar, et al.
Medicine and Science in Sports and Exercise
|
August 14, 2014
The effects of inspiratory muscle training in older adults
Dean E Mills, Michael A Johnson, Yvonne A Barnett, et al.
Brain Research
|
January 18, 1991
Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease
C Bancher, I Grundke-Iqbal, K Iqbal, et al.
Transplantation Proceedings
|
September 2, 1998
Relative bioavailability of Neoral versus Sandimmune in the presence of a P450IIIA and P-glycoprotein inhibitor
M G Choc, E A Mueller, W T Robinson, et al.
Science (New York, N.Y.)
|
February 21, 1986
Expression cloning of a lymphocyte homing receptor cDNA: ubiquitin is the reactive species
T St John, W M Gallatin, M Siegelman, et al.
Pharmaceutical Research
|
October 1, 1987
Multiple-dose pharmacokinetics of clozapine in patients
M G Choc, R G Lehr, F Hsuan, et al.
The Journal of Endocrinology
|
January 21, 2006
Somatostatin receptor subtype expression in the human heart: differential expression by myocytes and fibroblasts
William H T Smith, R Unnikrishnan Nair, Dawn Adamson, et al.
Journal of Clinical Pharmacology
|
February 1, 1997
Initial pharmacokinetics and bioavailability of PSC 833, a P-glycoprotein antagonist
R M Lush, B Meadows, A T Fojo, et al.
Page
of 8